During the past decade, Centre Hospitalier Bretagne Sud conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 1 clinical trials were completed, i.e. on average, 1.3% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Bretagne Sud" #1 sponsor was "University Hospital, Brest" with 16 trials, followed by "Rennes University Hospital" with 14 trials sponsored, "UNICANCER" with 11 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 7 trials sponsored and "Nantes University Hospital" with 7 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Bretagne Sud" #1 collaborator was "National Cancer Institute, France" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator. Other collaborators include 105 different institutions and companies that were collaborators in the rest 100 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Bretagne Sud" are "Breast Cancer" (6 trials), "Multiple Myeloma" (4 trials), "Heart Failure" (3 trials), "ALK Gene Rearrangement Positive" (2 trials) and "Estrogen Receptor Positive Tumor" (2 trials). Many other conditions were trialed in "Centre Hospitalier Bretagne Sud" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Bretagne Sud" are "Drug" (55 trials), "Other" (19 trials), "Radiation" (15 trials), "Device" (13 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Cyclophosphamide" (4 trials), "Atezolizumab" (3 trials), "Cisplatin" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Bretagne Sud" are 100 trials for "All" genders, 16 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier Bretagne Sud". undefined are not yet recruiting, 35 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Centre Hospitalier Bretagne Sud, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Bretagne Sud, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 28 trials that are defined as “Not Applicable".